Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 9Peutz-Jeghers Syndrome 3Exocrine Pancreatic Insufficiency 2Pancreatic Intraductal Neoplasms 1Hereditary pancreatitis 1Hereditary Sensory and Autonomic Neuropathies 1Fanconi Anemia, Complementation Group D1 1Dysplastic Nevus Syndrome 1Diabetes Mellitus 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Breast Neoplasms 1

Interventions

Surveys and Questionnaires 2Biopsy 2tislelizumab 1sofosbuvir-velpatasvir drug combination 1epalrestat 1donafenib 1Urine Specimen Collection 1Specimen Handling 1Secretin 1Risk Assessment 1Phlebotomy 1Pancreaticoduodenectomy 1Pancreas, Artificial 1Methods 1Magnetic Resonance Spectroscopy 1Lysine Acetyltransferase 5 1Liquid Biopsy 1Interviews as Topic 1Gastric Bypass 1Gastrectomy 1Exercise 1Endoscopic Mucosal Resection 1Clinical Laboratory Techniques 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Diabetes Mellitus × Secretin × Gastrointestinal × Clear all
NCT00587132 2013-06-24

Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma

Mayo Clinic

Phase 1/2 Terminated
4 enrolled 2 charts
Gastrointestinal

Diabetes Mellitus, Pancreatic Neoplasms, Peutz-Jeghers Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡